Ocular Therapeutix
OCUL
34 hedge funds and large institutions have $104M invested in Ocular Therapeutix in 2014 Q3 according to their latest regulatory filings, with 34 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SHI
SV Health Investors
Boston,
Massachusetts
|
+$38.2M |
| 2 |
Wellington Management Group
Boston,
Massachusetts
|
+$19M |
| 3 |
Capital Research Global Investors
Los Angeles,
California
|
+$13.6M |
| 4 |
RIM
RS Investment Management
San Francisco,
California
|
+$9.03M |
| 5 |
PCM
Pentwater Capital Management
Naples,
Florida
|
+$7.25M |
Top Sellers
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
BA
26
BlackRock Advisors
Wilmington,
Delaware
| $47K | +$46K | +3,111 | New |
|
|
SO
27
STRS Ohio
Columbus,
Ohio
| $30K | +$29.6K | +2,000 | New |
|
|
NFA
28
Nationwide Fund Advisors
Columbus,
Ohio
| $24K | +$24.1K | +1,632 | New |
|
|
U
29
UBS
Zurich,
Switzerland
| $19K | +$18.8K | +1,272 | New |
|
|
NFG
30
Next Financial Group
Houston,
Texas
| $10K | +$10.3K | +700 | New |
|
|
BJ
31
BlackRock Japan
Tokyo,
Japan
| $5K | +$5.15K | +348 | New |
|
|
SM
32
Sabby Management
Miami Beach,
Florida
| $4.45K | +$4.39M | +297,107 | New |
|
|
TDC
33
Thompson Davis & Co
Richmond,
Virginia
| $4K | +$3.7K | +250 | New |
|
34
Citigroup
New York
| $3K | +$2.97K | +201 | New |
|
OCUL Hedge Fund Activity: Q3 2014 in Review
34 of the 3,447 institutional investors tracked by Wall St. Rank reported a position in Ocular Therapeutix (OCUL) for Q3 2014, worth a combined $104M.
Buyers outnumbered sellers: 34 funds opened new OCUL positions and 0 closed out — a net gain of 34 holders — while 0 added to existing stakes and 0 trimmed.
The largest buyer was SV Health Investors, opening a new position worth an estimated $38.2M.
- 34 institutional investors held Ocular Therapeutix (OCUL) as of Q3 2014, up from 0 in Q2 2014.
- Funds reported $104M of Ocular Therapeutix stock for Q3 2014.
- 34 funds opened new Ocular Therapeutix positions in Q3 2014 and 0 closed out, a net change of +34 holders.
- The largest Ocular Therapeutix buyer in Q3 2014 was SV Health Investors, an estimated $38.2M added.
Based on aggregated 13F filings for Q3 2014.